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Binocular rivalry occurs when different images are presented simultaneously to corresponding points within the left and right eyes. Under
these conditions, the observer’s perception will alternate between the two perceptual alternatives. Motivated by the reported link
between the rate of perceptual alternations, symptoms of psychosis and an incidental observation that the rhythmicity of perceptual
alternations during binocular rivalry was greatly increased 10 h after the consumption of LSD, this study aimed to investigate the
pharmacology underlying binocular rivalry and to explore the connection between the timing of perceptual switching and psychosis.
Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine, PY) was chosen for the study because, like LSD, it is known to act as an agonist at
serotonin (5-HT)1A and 5-HT2A receptors and to produce an altered state sometimes marked by psychosis-like symptoms. A total of 12
healthy human volunteers were tested under placebo, low-dose (115 mg/kg) and high-dose (250mg/kg) PY conditions. In line with
predictions, under both low- and high-dose conditions, the results show that at 90 min postadministration (the peak of drug action), rate
and rhythmicity of perceptual alternations were significantly reduced from placebo levels. Following the 90 min testing period, the
perceptual switch rate successively increased, with some individuals showing increases well beyond pretest levels at the final testing,
360 min postadministration. However, as some subjects had still not returned to pretest levels by this time, the mean phase duration at
360 min was not found to differ significantly from placebo. Reflecting the drug-induced changes in rivalry phase durations, subjects
showed clear changes in psychological state as indexed by the 5D-ASC (altered states of consciousness) rating scales. This study suggests
the involvement of serotonergic pathways in binocular rivalry and supports the previously proposed role of a brainstem oscillator in
perceptual rivalry alternations and symptoms of psychosis.

























































Understanding the neural underpinnings of consciousness
has long been a goal of neuroscientists. To this end,
considerable attention has been focused recently on
different forms of perceptual rivalry as it is a phenomenon
characterized by switches in perception that occur despite a
constant, if ambiguous, sensory input. Binocular rivalry is a
specific form of perceptual rivalry that results when two
different images are simultaneously presented to the
corresponding retinal location in the left and right eye
(Wheatstone, 1838; Walker, 1975). Under these conditions,
the observer will experience alternations between awareness
and suppression of the two ‘rivaling’ images. Currently,
the debate is focused on the relative influences of early vs
late visual processes (Blake and Logothetis, 2002), with
the majority of research using a variety of imaging
(Kleinschmidt et al, 1998; Tong and Engel, 2001) and
recording (Leopold and Logothetis, 1996; Tononi et al,
1998) techniques aimed at identifying the location and
nature of neuronal activity that ‘correlates’ with perceptual
awareness and suppression. Relatively little has been done,
however, to investigate either the nature of the ‘switch’ that
drives the alternations in visual awareness or the pharma-
cology underlying the rivalry process. This study aims to
look specifically at both of these areas.
Apart from its relevance to consciousness research,
binocular rivalry is also of clinical relevance as it has been
suggested that perceptual switches characteristic of all
forms of rivalry reflect the activity of an oscillator, whose
rhythms are fundamental to a number of brain functions
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and associated variations in conscious state (Pettigrew,
2001). In support of this proposal, it has been shown that
extreme deviations from the norm in rivalry rate corre-
spond with symptoms of psychosis (Pettigrew and Miller,
1998; Leonard et al, 2001; Miller et al, 2003). Further
strengthening this link between deviations in perceptual
rivalry rhythm and fluctuations in conscious state was the
incidental observation that the rhythmicity of perceptual
alternations during binocular rivalry was greatly increased
10 h after the reported consumption of LSD (Carter and
Pettigrew, 2003). This subject showed a rhythmic, multi-
modal pattern of harmonic and forbidden intervals, with
perceptual switches occurring only after a duration of
around 0.9, 1.8, 2.8, or 3.7 s, while few switches were
reported after 0.5, 1.5, or 2.5 s. In line with this observation,
there was a recent study showing that ayahuasca, a
dimethyltryptamine-containing hallucinogenic brew made
from psychoactive plants from the Amazon, significantly
alters the rate of perceptual switches (Frecska et al, 2004).
Specifically, the oscillator model proposes that a number
of brainstem nuclei encompassing regions such as the raphe
nuclei, the ventral tegmental area, and the locus coeruleus
are responsible for the generation of these rhythms in the
brain. Each of these nuclei is responsible for the respective
release of serotonin (5-HT) (Jacobs and Azmitia, 1992),
dopamine (Dahlstrom and Fuxe, 1964) and noradrenalin
(Foote et al, 1983) into the cortex. The spontaneous,
synchronous, and tonic activity characteristic of the
neurons in these regions (Aston-Jones and Bloom, 1981;
Grace and Onn, 1989; Jacobs and Fornal, 1991) makes them
well suited for the generation and propagation of rhythms
throughout the brain. In addition, the existence of direct
inputs both between these brainstem regions (Pickel et al,
1977; Herve et al, 1987; Grenhoff et al, 1993) and higher
cortical areas allows for a system that can be easily
modulated by top-down regulation (Svensson and Tung,
1989; Jodo et al, 1998; Brown et al, 2002). It is proposed that
the pacemaker activity of these brainstem nuclei is
responsible for pulsatile neurotransmitter release into the
cortex, at a rate and rhythm that is modulated both by other
brainstem regions and fluctuations in cortical activity. The
visual alternations induced during perceptual rivalry are
believed to reflect activity of this brainstem oscillator
(Pettigrew, 2001).
Given the relevance of the above-mentioned LSD
observation to the proposed oscillator model of perceptual
rivalry and its link to clinical psychosis, the authors of the
current study were motivated to investigate this effect
further. However, because LSD is known to act at multiple
receptors (5-HT1A/2A, D2, and alpha1) with a half-life of
B3.6 h (Lim et al, 1988) and an effect time ranging from 8
to 12 h, it was deemed preferable to use psilocybin (4-
phosphoryloxy-N,N-dimethyltryptamine, PY), a compound
with relatively comparable hallucinogenic properties but
greater receptor specificity and a shorter duration of action
(half-lifeB2.6 h), with symptoms generally dissipating
within 4 to 5 h (Hasler et al, 1997; Hasler et al, 2004).
Receptor binding studies in rats revealed that psilocin
(4-hydroxy-N,N-dimethyltryptamine), the first and pharma-
cologically active metabolite of PY (Hasler et al, 1997)
primarily binds to 5-HT2A receptors (Ki¼ 6 nM), although
with a lower affinity also to 5-HT1A sites (Ki¼ 190 nM
(McKenna et al, 1990). In line with this receptor affinity,
activation of 5-HT2A receptors leads to a general increase in
activity throughout the cortex, believed to be driven
predominantly by the induction of glutamatergic excitatory
postsynaptic potentials in layer V pyramidal cells of the
neocortex (Aghajanian and Marek, 1997). Specifically, this
effect is most pronounced in the frontal cortex (Vollenwei-
der et al, 1997), where there is an increased density of 5-
HT2A receptors as compared to more posterior regions
(Wong et al, 1987). It has been proposed that the other main
effect of PY’s activation of the somatodendritic 5-HT1A
autoreceptors located on the raphe neurons is an inhibition
of tonic firing and associated reduced release of serotonin
from this region (Aghajanian and Hailgler, 1975).
On the basis of the known properties of PY and the clearly
outlined nature of the proposed brainstem oscillator, a
number of predictions were made. (1) That the inhibition of
5-HT release from the raphe nucleus in combination with
an increase in cortical activation induced by PY would
cause a reduction in the relative influence of the brainstem
oscillator and consequently rivalry alternations would
become less frequent and less regular. (2) In line with the
observed increase in rivalry rhythmicity 10 h after the
reported consumption of LSD, it was further speculated that
following the peak effects of the drugs, there may be a
‘rebound effect’ with a reduction in cortical activity leading
to increases in the relative ‘strength’ of the oscillator. (3)
Observed effects on rivalry alterations would be associated
with subjective changes in conscious state in a dose-
dependent manner.
MATERIALS AND METHODS
This study was approved by the Ethics Committee of the
University Hospital of Psychiatry, Zurich, and the use of PY
was authorized by the Swiss Federal Office for Public
Health, Department of Pharmacology and Narcotics, Bern.
Subjects
A total of 12 healthy volunteers (six female and six male)
aged between 22 and 33 years (mean 26.873.6 years)
were recruited through advertisement from the local univer-
sity and technical college. After being informed by a
written and oral description of the aim of the study, the
procedures involved, as well as the effects and possible
risks of PY administration, all volunteers were asked to
give their written consent as a requirement of participation.
All subjects had normal or corrected to normal vision
and were healthy according to medical history, clinical
examination, electrocardiography, and blood analysis.
They were also deemed by psychiatric interview to have
no personal or family (first-degree relatives) history of
major psychiatric disorder nor evidence for regular
alcohol or substance abuse. Six of the participants reported
having previous experience with PY through the ingestion
of psilocybe mushrooms; the other half were PY naı¨ve.
Subjects were reimbursed for their time and they were
instructed that they were free to withdraw from the study
at any time.
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PY was obtained through the Swiss Federal Office for Public
Health, Department of Pharmacology and Narcotics, Bern.
PY capsules (1 and 5 mg) were prepared at the pharmacy of
the Cantonal Hospital of Aarau, Switzerland. Quality control
comprised tests for identity, purity, and uniformity of
content. The PY and lactose placebo were prepared in
gelatin capsules of identical appearance. Based on previous
PY studies in human volunteers (Vollenweider et al, 1998;
Hasler et al, 2004), the medium (115 mg/kg) and the high
dose (250 mg/kg) of PY used in the present study were
expected to induce changes in the subject’s visual percep-
tion without seriously affecting their thought patterns or
eroding their self–nonself boundaries. A double-blind
placebo-controlled within-subject design with the three
different experimental conditions was used. Subjects were
tested on three full days, each separated by at least 14 days.
On each of the three days subjects received placebo, a low
and a high dose of PY respectively, with the order of
administration counterbalanced.
Binocular Rivalry
Stationary green vertical and horizontal gratings were
presented to the subject’s left and right eye, respectively.
Viewed from a distance of 60 cm, the gratings had a spatial
frequency of 1.5 cycles/degree of visual angle and were
presented as a disc that subtended 41 of visual angle. The
images were generated in Matlab, using the Psychophysics
Toolbox extensions (Brainard, 1997; Pelli, 1997) and
displayed on an Image System monochrome computer
monitor (green, P46 phosphor, persistence¼ 300 ns). The
vertical and horizontal gratings were presented alternately,
in rapid succession, at a rate of 120 Hz. Subjects viewed the
display through liquid crystal shutters that alternately
blocked presentation to the left and the right eye in
synchrony with the stimuli. Using this method, it was
possible to present the conflicting stimuli to the corre-
sponding retinal location of each eye, without perceptual
flicker or crosstalk.
Responses were recorded on a modified computer key-
board. Two raised buttons, one with a ridge aligned
perpendicular to the observer and the other running from
left to right, were placed on top of the B and V key,
respectively. Subjects were instructed to focus only on the
orientation of the gratings within the circular patch.
Subjects reported the predominance of the vertical gratings
by pushing the button with a ridge aligned along a vertical
orientation and the predominance of the horizontal gratings
by pushing the button on which there was a ridge aligned
along a horizontal orientation. If the subject experienced a
combination of the two orientations, either as a grid or a
patchwork, they were instructed to press the space bar, but
only in cases when the mixed percept was stable and not
considered to be ‘transitional’. Data for each testing period
were collected using commercial software (Bireme.com.au)
in a block consisting of 4 100 s trials, with subjects
receiving a 30 s break between each trial.
In order to insure that subjects understood the task
requirements and were capable of reporting their visual
experiences accurately during drug-altered states, prior to
each binocular rivalry test, they were asked to report their
perceptual experience during the presentation of a 1 min
movie of simulated rivalry. This ‘catch-trial movie’ con-
sisted of the sequential presentation of vertical or horizontal
gratings (to both eyes). Each respective grating image was
identical to the grating stimuli used during the binocular
rivalry condition and was presented for between 0.5 and 5 s
before being replaced by the grating of the alternative
orientation. During this time, subjects were given the same
viewing and reporting instructions as those outlined for
binocular rivalry. In this way, information regarding
response time and accuracy of response was obtained. Four
different versions of the catch-trial movie sequence were
used throughout the testing in a randomized order.
Psychological Ratings
The German version of the adjective mood rating scale
(AMRS) (Janke and Debus, 1978) and the altered state of
consciousness (5D-ASC) rating scale (Dittrich, 1998;
Dittrich et al, 1999) were used to assess the subjective
effects under placebo and PY. Both the AMRS and ASC scale
had previously been shown to be sensitive to psychological
effects of PY in humans (Vollenweider et al, 1997, 1998;
Hasler et al, 2004). The methodology and results pertaining
to the AMRS component of this study will not be discussed
here as they will be submitted for publication separately.
The 5D-ASC rating scale is a visual-analogue scale that
measures alterations in waking consciousness, including
changes in mood, perception, experience of oneself and of
the environment, as well as disordered thought. The ASC
scale consisted of 94 individual statements such as ‘I heard
tones and noises without knowing where they came from’
and subjects were required to mark their current state along
a 100 mm line between ‘No, not more than normal’ or ‘Yes,
very much more than normal’. Each of the 94 items was
given a score from 0 to 100, reflecting the distance of the
mark in millimeters from the end indicating no change. The
items and their associated scores were grouped to yield five
main scales (factors) comprising several item clusters. (1)
‘Oceanic Boundlessness’ (OB), measures derealization and
depersonalization accompanied with changes in affect
ranging from heightened mood to euphoria and/or exalta-
tion, and alterations in the sense of time. The corresponding
item clusters are ‘positive derealization’, ‘positive deperso-
nalization’, ‘altered sense of time’, ‘positive mood’, and
‘mania-like experience’. (2) ‘Anxious Ego Dissolution’
(AED) measures ego disintegration associated with loss of
self-control, disordered thought, arousal, and anxiety. The
item clusters are ‘anxious derealization’, ‘disordered
thought’, ‘delusion’, ‘fear of loss of thought control’, and
‘fear of loss of body control’. (3) ‘Visionary Restructuraliza-
tion’ (VR) includes the item clusters ‘elementary halluci-
nations’ (EH), ‘visual (pseudo-) hallucinations’ (VH),
‘synesthesia’ (SY), ‘changed meaning of percepts’ (CMP),
‘facilitated recollection’ (FR), and ‘facilitated imagination’
(FI). (4) ‘Auditory Alterations’ (AA) refers to acoustic
hallucinations and distortions in auditory experiences. (5)
The dimension ‘Reduction of Vigilance’ (RV) relates to
states of drowsiness, reduced alertness, and impairment of
cognitive function. Subjects completed the 5D-ASC rating
scale 110 min after drug administration and were thereby
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instructed to rate their whole experience since drug intake
(0–110 min).
Experimental Protocol
Before participating in either of the experimental condi-
tions, subjects were taken through each of the measures to
insure that they were familiar and comfortable with all tests
upon arrival for their first experimental day. For each of the
three experiment days, subjects were instructed to have a
light breakfast prior to arrival at the hospital. Before testing
began, blood pressure and heart rate was measured and
subsequently monitored at hourly intervals throughout the
day. To obtain baseline scores, subjects were first tested on
binocular rivalry. Following this, the placebo/PY was self-
administered by oral ingestion. To minimize anxiety,
subjects were then advised to relax and allow themselves
to become comfortable with any perceptual or cognitive
changes experienced. Binocular rivalry was measured again
90, 180, 270, and 360 min after drug intake. After 110 min,
subjects were also asked to fill out the 5D-ASC rating scale.
Subjects finished participation in the study approximately
7 h after PY consumption and were examined by the
principal investigator before being deemed fit to be
released.
At a number of intervals throughout the day subjects were
additionally tested on time perception and working memory
measures. The results from those experiments are not
reported here as they will be submitted for publication
separately. Subjects were also presented with the KDE
ambiguously rotating sphere (Wallach and O’Connell,
1953), for the same 4 100 s trial period used during
binocular rivalry. However, throughout the course of the
testing sessions subjects reported an increased predomi-
nance of the combined percept of two spheres rotating
‘inside themselves’. As this became the most dominant
percept over the course of testing, it was decided that the
rate and rhythm of perceptual alternations could not validly
be assessed from the limited remaining data, so results from
this portion of the study have not been presented.
Statistical Analysis
For binocular rivalry and the catch-trial movie, significant
main effects and interactions of time and dose were
determined using Wilks–Lambda multivariate test for
repeated measures. In the case where significance was
found, Tukey’s post hoc pair-wise comparisons were
performed. Drug dose effects were only considered relative
to each time point, while ‘time of day’ or ‘effect of repeated
test exposure’ was considered only for the placebo
condition.
To test for significant effects of drug dose on the five ASC
scale dimensions (OB, AED, VR, AC, VR), a repeated
measures analysis of variance (ANOVA) was used. Given
the emphasis of this study on visual perception, an
additional repeated measures ANOVA, with treatment
(placebo vs doses of PY) and VR subscale scores, was
conducted to explore whether the different doses of PY
produced different patterns of visual alterations. Based on
significant main effects or interactions, Tukey’s post hoc
comparisons were performed. All data were analyzed using
STATISTICA 6.0 (StatSoftt) for Windows and the criterion
for significance was set at po0.05.
RESULTS
Binocular Rivalry
One subject reported seeing a grid or patchwork combina-
tion of the vertical and horizontal gratings for the entire
testing period, so the response data from this subject were
excluded from the analysis.
Phase duration. The mean phase duration was calculated as
the average duration of time (s) that the subject reported
uninterrupted dominance of the respective target, for each
of the five testing time points. Periods of mixed percept
were not included. Significance was found for the main
effects of time (F(4,7)¼ 7.52; po0.05) and dose (F(2,9)¼ 6.80;
po0.05) and a time–dose interaction (F(8,3)¼ 9.01; po0.05)
(Figure 1a). Effects of both gender and prior exposure to PY
were considered but were found to have no significant
influence on rivalry phase duration (p¼ 0.66 and 0.95,
respectively). Subsequent post hoc analysis revealed that the
phase duration during the low dose condition differed from
placebo only at the ‘peak’ time 90 min postadministration
Figure 1 Binocular rivalry phase duration (time between perceptual
switches) after administration of placebo (broken dark gray line), low- (light
gray), and high- (black) dose PY. (a) Mean phase duration on the high dose
of PY was found to be longer compared to placebo at both 90 and 180 min
following drug administration. While the phase durations on low-dose PY
were significantly longer only at 90 min, compared to placebo. (b) The CV
(variance in phase duration relative to the individual’s mean duration) for
the high dose showed significantly more variability than placebo, at 90 and
180 min. No difference was found between the low dose and the placebo
or high dose. Significance is denoted by * for po0.01 and **for po0.001,
and the bars represent measures of standard error.
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(placebo: m¼ 2.02, s¼ 0.49; 115 mgPY/kg: m¼ 2.71, s¼ 0.70;
po0.001). While the high-dose phase duration was found to
be significantly greater than the corresponding placebo
measure at both 90 min (250 mgPY/kg: m¼ 3.04, s¼ 0.95;
po0.001) and 180 min (placebo: m¼ 2.04, s¼ 0.61;
250 mgPY/kg: m¼ 2.85, s¼ 1.12; po0.001), at no single time
point was a significant difference observed between the low-
and the high-dose condition. No effect of time was observed
within the placebo condition.
In order to test whether the overall drug effect size
differed significantly between the two dose conditions,
effect size was calculated as the mean area under the data–
time curve (AUC) for all subjects for each of the three
conditions. The AUC values were calculated with respect to
relative increase in phase duration from pretest over the
entire testing time. To reduce the influence of the
substantial degree of between-subject variability, the Page’s
L nonparametric trend analysis (Page, 1963) was performed.
A significant difference between the AUC for placebo
(m¼ 4.85, s¼ 74.71) low dose (m¼ 86.43, s¼ 102.02) and
high dose (m¼ 170.75, s¼ 210.14) was found (Page’s
L¼ 144; po0.01).
The total period of time perceiving the mixed percept was
found to be slightly greater after administration of PY for
both low- and high-dose PY compared to placebo levels;
however, neither the effect of time nor dose was found to be
significant (time: F(4,7)¼ 2.12; p¼NS; dose: F(2,9)¼ 1.13;
p¼NS).
Coefficient of variation (CV). In order to determine
whether there was an effect of time or drug on the
regularity/rhythmicity of rivalry alternations, CV values
were calculated and compared. Here, the CV represents a
measure of variance in rivalry phase duration relative to the
individual’s mean phase duration. CV was calculated for
each subject, and these scores were then averaged to
determine the mean CV for each condition. There was a
significant main effect of time (F(4,7)¼ 15.83; po0.01) and
dose (F(2,9)¼ 9.10; po0.01) on CV; however, no time–dose
interaction was observed (Figure 1b). Post hoc analysis
showed that the high-dose condition had significantly
more variability compared to placebo, at 90 min (placebo:
m¼ 0.46, s¼ 0.10; 250 mgPY/kg: m¼ 0.62, s¼ 0.19; po0.001)
and 180 min (placebo: m¼ 0.43, s¼ 0.09; 250 mgPY/kg:
m¼ 0.58, s¼ 0.16; po0.01). No significant difference in
CV was found between the low dose and either placebo or
the high dose, for any of the five time points. Neither was
any difference found between time points within the
placebo condition.
Perceptual bias. Proportion of perceptual dominance was
unaffected by PY administration. At both the low and the
high dose, there was no change in the relative predominance
of vertical or horizontal lines experienced (time:
F(4,7)¼ 1.90; p¼NS; dose: F(2,9)¼ 0.18; p¼NS), nor in the
absolute magnitude of perceptual predominance (time:
F(4,7)¼ 3.32; p¼NS; dose: F(2,9)¼ 4.23; p¼NS).
Replication of LSD observation. At no time point after
administration of PY was there found to be a significant
increase in the overall rate or rhythmicity of perceptual
switches, nor did any subject show the harmonic-type
oscillations seen in the incidental LSD observation that
motivated the study (Carter and Pettigrew, 2003). However,
looking at the individual data, it can be seen that after the
initial increase in phase duration shown by all subjects at
90 min, by 270 min the reported perceptual switches for all
subjects became increasingly faster, such that by 360 min
some, but not all, subjects were switching at intervals that
were shorter and more regular than their pretest levels
(Figure 2). Therefore, as some subjects had still not
returned to pretest levels at this final testing time, it is
not possible to know from these data if this ‘rebound’
increase in rate would have eventually been observed in all
subjects if testing had been extended.
Rivalry pretest catch trials. Key press responses to the
perceptual switches presented in the rivalry catch-trial
movie were assessed with respect to response accuracy
(total number of incorrect responses) for each individual
and response time (average elapsed time between image
presentation and key press). Response accuracy was not
affected by dose (F(2,10)¼ 0.48; p¼NS) or time (F(4,8)¼ 1.67;
p¼NS) (Figure 3a). For response time, there was a
significant main effect of time (F(4,8)¼ 20.92; po0.001)
and dose (F(2,10)¼ 5.52; po0.05), but no time–dose inter-
Figure 2 Investigating the ‘rebound’ increase in binocular rivalry rate and
rythmicity as observed in the previously published LSD observation. (a)
While no significant effect was found across all subjects, some individuals
showed an increase in rate of perceptual switches, after the ‘peak’ 90 min
testing, that continued to increase below pretest levels until the 360 min
testing. (b) Phase duration histograms for one individual (broken dark gray
line) show the initial reduction and subsequent gradual increase in rate and
rhythmicity as seen in some individuals.
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action (Figure 3b). The response times under the high dose
were significantly slower compared to placebo, at 90 min
(placebo: m¼ 0.36, s¼ 0.05; 250 mgPY/kg: m¼ 0.49, s¼ 0.10;
po0.001) and 180 min (placebo: m¼ 0.34, s¼ 0.05;
250 mgPY/kg: m¼ 0.42, s¼ 0.08; po0.01). No significant
difference was found between the low dose and either
placebo or the high dose, for any of the five time points.
Neither was any difference found between time points
within the placebo condition.
Psychological Ratings
The peak effects of PY on the five main factors of the ASC
dimensions compared to placebo are summarized in
Figure 4a. PY increased scores of the five ASC factors in a
dose-dependent manner, with significant main effects found
for drug (F(2,22)¼ 23.68; po0.00001) and factor
(F(4,44)¼ 10.79; po0.0001), and a treatmentASC–factor
interaction (F(8,88)¼ 8.24; po0.0001). Post hoc analysis
revealed that the high dose caused significant increases in
each of the five factors (OB: po0.001; AED: po0.001; VR:
po0.001; AA: po0.05; VR: po0.01), while the low dose of
PY significantly increased only scores for OB (po0.01) and
VR (po0.01) from placebo levels. Subsequent analysis of
the ASC item clusters showed that the increase in OB scores
after high-dose PY was mainly due to moderate increases in
‘derealization phenomena’, ‘heightened mood’, and ‘mania-
like’ symptoms, while the increase in AED was attributable
to moderate ‘thought disturbances’ followed by slight
increases in ‘anxious derealization’, ‘loss of thought’, and
‘loss of body’ control items. With respect to ‘VR’ (illustrated
in Figure 4b), the high dose resulted in a significant increase
in each of the six subscales, with the greatest effects seen in
‘EHs’ (po0.001), ‘changed meaning of percept’ (po0.001),
and ‘SY’ (po0.001). The only two measures found to be
significantly increased from placebo levels after the low
dose of PY were ‘EHs’ (po0.05) such as light flashes or
geometric figures and ‘CMP’ (po0.01).
DISCUSSION
PY acts as an agonist at both the 5-HT2A and 5-HT1A
receptors. Activation of these receptor sites simultaneously
increases cortical activity (Vollenweider et al, 1997), and
reduces tonic release of 5-HT from the raphe nucleus
(Aghajanian and Hailgler, 1975). As a consequence, it was
predicted that administration of PY would lead to a
reduction in binocular rivalry switch rate and rhythmicity
due to the effective reduction in the relative amplitude of
the rhythm generated and a simultaneous increase in the
strength of the cortical activity/feedback to the brain stem
regions. In line with this prediction, PY was found to dose
dependently increase binocular rivalry phase duration in a
manner that reflected subjective changes in conscious state.
Figure 3 Rivalry pretest catch-trial response for placebo (broken dark
gray line), low- (light gray), and high- (black) dose PY. (a) Response
accuracy was not significantly affected by either the low or high dose of PY.
(b) However, mean response time on the high dose was slower than
placebo at 90 and 180 min. The low-dose condition did not differ
significantly from either the high dose or placebo. Significance is denoted by
* for po0.01 and ** for po0.001, and the bars represent measures of
standard error.
Figure 4 Results from the ASC questionnaire for placebo (white), low-
(light gray), and high-dose (dark gray) drug conditions, displaying the
subjective effects of drug from the period 0 and 110 min postadministra-
tion. Significant difference from placebo levels is denoted by * for po0.05,
** for po0.01, and *** for po0.001, and the bars represent measures of
standard error. (a) The percentage of the total possible score for each of
the five ASC main factors: OB, and AED, VR, AA, and RV. On the high
dose, all factors were significantly higher than placebo, whereas on the low
dose only OB and VR, were significantly different from placebo. (b) The
scores for each of the six VR subscales: ‘EH’, ‘VH’, ‘SY’, ‘CMP’, ‘FR’, and ‘FI’.
The high dose resulted in a significant increase in each of the six subscales;
however, the greatest effects were seen in EH, CMP, and SY. After low-
dose PY, only two measures were found to differ significantly from placebo.
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The mean duration of each successive phase of perceptual
dominance (time between switches) was greater than
placebo levels 90 min after administration of both the high
(250 mg/kg) and low (115 mg/kg) dose of PY. After 180 min,
the phase duration remained significantly greater than
placebo on the high-dose, but not on the low-dose
condition. Using AUC calculations, which combine effect
size and duration information, the calculated overall change
in phase duration (s) over the entire testing time (min) was
found to be dose dependently increased by PY. With respect
to regularity of rivalry switches, the mean CV for each
subject (variance in rivalry phase duration relative to the
individual’s mean phase duration) was significantly greater
than placebo at both 90 and 180 min on the high dose, but
no difference was seen between the low dose and placebo.
The harmonic oscillations in perception observed in the
subject who subsequently reported taking LSD the night
before being tested (Carter and Pettigrew, 2003) were not
seen in any subject on either the high or the low dose of this
study. However, if the individual data are considered, it can
be seen that while phase durations do increase from pretest
levels 90 min postdrug intake on the low and high dose,
after 180 min all subjects were returning back to pretest. By
270 and 360 min, a number of subjects showed a ‘rebound’
increase in rate and rhythmicity beyond pretest levels.
However, as the majority of subjects had still not returned
to pretest levels at this point, the overall effect did not reach
significance. These results raise questions about whether or
not more subjects would have continued to show reductions
in phase duration if testing had been extended out a further
1 or 2 h.
As the alternations in perceptual state are measured
indirectly by subjects reporting changes in their visual
perception via key press, it could be argued that any
inappropriate button response or substantial reduction in
reaction time may result in ‘missed’ switches. However,
subjects showed no increase in the percentage of incorrect
responses during the pretest ‘catch-trial movie’ and only a
minor increase in response time compared to placebo on
the high dose (0.13 s). This is in agreement with subjective
reports that the task of determining the relative dominance
of vertical and horizontal gratings remained possible,
despite the gratings often appearing to fluctuate in color
and depth or even taking on human characteristics. For
example, one subject commented that the vertical and
horizontal gratings appeared to be at war with each other,
with each successively ‘reclaiming the other’s territory’.
Consequently, it seems likely that the binocular rivalry
effects reported in this study reflect real changes in the
individual’s perceptual state rather than an inability to
perform the task correctly. An alternative criticism to this
study is that PY might be influencing rivalry through drug-
induced changes of visual sensitivity. This possibility is
particularly relevant given that binocular rivalry rate can be
slowed down by reducing the relative strength of the
stimulus (Levelt, 1965; Fahle, 1982) and PY is known to
induce distortions in visual perception. However, results
from a second study partly motivated by this concern
showed that, while a medium dose of PY (215 mg/kg)
impaired coherence sensitivity for random dot patterns,
contrast sensitivity for drifting gratings was not effected
(Carter et al, 2004). This result indicates that the visual
disturbances associated with this drug are unlikely to reflect
changes at either the retinal level or in the transfer of
information from the retina through the lateral geniculate
nucleus to the primary visual cortex.
With respect to the relevance of binocular rivalry to
symptoms of psychosis, it was predicted that any observed
effects on rivalry alterations would be associated, in a dose-
dependent manner, with subjective changes in conscious
state. In line with this prediction and previous reports
(Hasler et al, 2004), PY was found to increase scores of the
ASC factors in a dose-dependent manner. Compared to
placebo levels, the high-dose PY significantly increased each
of the five factors: OB, AED, VR, AA, and RV, while the low
dose of PY increased only scores for OB and VR in a
statistically significant manner. The observation that the
degree of effect on the rivalry rhythm paralleled the dose-
dependent differences in subjective changes in conscious
state induced by PY is in line with the proposed link
between deviations in the brainstem rhythms and symp-
toms of psychosis. It also emphasizes the potential
diagnostic value that binocular rivalry might offer the field
of psychiatry. In further support of this point, it was noticed
that the only subject who showed a mild and transient
psychotic reaction to PY also had the greatest deviation of
rivalry rate induced by the drug.
While the results of this study are in line with those
predicted by the brainstem oscillator model, the authors of
the current study acknowledge that standing alone they are
not sufficient to rule out other possible mechanisms by
which PY may effect rivalry. Rather, this study should be
considered as an initial step in understanding the pharma-
cological interactions underlying conscious perception and
suggests that any competing theory of rivalry should be
equally able to account for considerable changes in rate
associated with such modulations in neurotransmitter
levels. With respect to future studies, a number of
interesting questions have been raised by the results
reported here. The most obvious question is whether PY’s
influence on binocular rivalry is mediated through either
the 5-HT1A or 5-HT2A receptor system exclusively, or if both
receptors are involved. As it has been shown previously that
the majority of subjective effects induced by PY are blocked
by the selective 5-HT2A antagonist ketanserin (Vollenweider
et al, 1998), it would be particularly interesting to learn
whether pretreatment with ketanserin can also block the
effects of PY on perceptual rivalry, or if the subjective
experience and the perceptual rivalry phenomena can be
dissociated.
CONCLUSION
These findings show that the 5-HT1A and 5-HT2A agonist PY
dose dependently reduces rivalry rate and rhythmicity in a
manner reflecting subjective changes in conscious state.
While it is premature to draw any firm conclusions
regarding either the physiological basis of binocular rivalry
or psychosis on the basis of this result alone, taken in
combination with previous studies linking rivalry rate with
bi-polar disorder and schizophrenia, it reinforces the idea
that the pattern of switching in rivalry may reflect some
fundamental processes essential to the maintenance of
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normal brain function. These data also show that while the
rate of binocular rivalry switches is generally very stable
within an individual (Pettigrew and Miller, 1998), this
rhythm can be profoundly and reliably altered through
pharmacological manipulation. Perhaps, most significantly,
this result highlights the need and potential benefit of
incorporating the expertise and interests of the relatively
independent fields of psychopharmacology, vision science,
and mental health in future research into perception and
consciousness.
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